Sonablate HIFU Non-Invasive Prostate Cancer Treatment Dubai

Related Services

الخدمات ذات الصلة

Prostate Cancer Treatment

Sonablate HIFU

Sonablate HIFU for the treatment of prostate cancer is exclusively available at CMC Hospital Dubai.  Please read our Sonablate HIFU press release on this advanced therapy for prostate cancer.

High-intensity focused ultrasound (HIFU) is a non-invasive procedure that utilizes high-frequency sound waves to precisely target and destroy cancerous tissue. This treatment modality has emerged as a promising alternative to traditional prostate cancer therapies, such as surgery and radiation therapy, offering several advantages, including reduced side effects, improved quality of life, and shorter recovery times.

Sonablate HIFU Prostate Cancer Treatment
HIFU employs a focused beam of ultrasound waves to generate intense heat within the targeted tissue, effectively destroying cancer cells while leaving surrounding healthy tissue intact. The ultrasound waves are delivered through a specialized probe inserted into the rectum, allowing for precise targeting of the prostate gland.

Indications for HIFU Prostate Cancer Treatment

Sonablate HIFU is primarily indicated for the treatment of localized prostate cancer, meaning the cancer is confined to the prostate gland and has not spread to other parts of the body. HIFU may be considered an appropriate treatment option for patients who:

  • Have early-stage prostate cancer (Gleason score 7 or less)
  • Are not suitable candidates for surgery or radiation therapy due to underlying medical conditions or personal preferences
  • Desire a minimally invasive treatment approach with minimal side effects

Sonablate HIFU Prostate Cancer Procedure

Sonablate HIFU is typically performed under general anesthesia to ensure patient comfort during the procedure. The procedure involves the following steps:

  1. Imaging: Ultrasound imaging is used to accurately map the prostate gland and identify the target area for treatment.
  2. Probe Placement: A specialized HIFU probe is inserted into the rectum, allowing for precise delivery of ultrasound waves to the prostate.
  3. Treatment Delivery: The HIFU machine generates a focused beam of ultrasound waves, heating and destroying the targeted cancer cells.
  4. Monitoring: Throughout the procedure, the patient’s vital signs and the temperature Sonablate HIFUof the treated tissue are closely monitored to ensure safety and efficacy.
  5. Catheter Placement: A urinary catheter may be inserted to temporarily drain urine, allowing for post-treatment swelling to subside.

Benefits of Sonablate HIFU Prostate Cancer Treatment

Sonablate HIFU offers several advantages over traditional prostate cancer therapies, including:

  • Real-time ultrasound-derived feedback
  • Non-invasive, bloodless ablation
  • Adjustable for each dose of HIFU energy
  • Repeatable procedure, if needed
  • Radiation-free
  • Healthy tissue sparing
  • Minimal side effects

Sonablate HIFU has emerged as a promising and effective treatment option for localized prostate cancer, offering several advantages over traditional therapies. Its minimally invasive nature, precise targeting, and minimal side effects make it an attractive option for patients seeking a less invasive and more comfortable treatment approach. As research and clinical experience with HIFU continue to expand, its role in the management of prostate cancer is expected to grow.

Sonablate HIFU

Sonablate HIFU


HIFU stands for high-intensity focused ultrasound. It is a non-invasive treatment for prostate cancer that uses ultrasound waves to destroy cancerous cells.

HIFU is a good option for men with localized prostate cancer. It is also an option for men who are not eligible for surgery or radiation therapy.

The most common side effects of HIFU prostate cancer treatment are urinary tract problems and sexual side effects. These side effects are usually temporary.

HIFU prostate cancer treatment is very effective for treating localized prostate cancer. Studies have shown that it can cure up to 90% of men with localized prostate cancer.

Start chat
Chat with us
I’d like to book an appointment